Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Watch
Expert ConversationsShows & PodcastNews & Analysis
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Daniel J. George, MD

Advertisement

Articles by Daniel J. George, MD

New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

ByDaniel J. George, MD
October 2nd 2019

For patients with advanced prostate cancer, new findings from the CARD trial could change their daily treatment.

Advertisement

Latest Updated Articles

  • New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer
    New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

    October 2nd 2019



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Navigation Boosts Cascade Genetic Testing in Relatives of BRCA Carriers

2

FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer

3

Daily Symptom Shifts Linked to Quality of Life in Metastatic Breast Cancer

4

Multidisciplinary Support for Patients with Metastatic Triple-Negative Breast Cancer

5

Managing Oral and Ocular Toxicities in Metastatic Triple-Negative Breast Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us